Lynette Chee

1.2k citations

29 papers · 320 indexed · h-index 9

Impact in

Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research

Papers in ⓘ

Hematology 18
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 5
Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Karin Thursky (2 shared papers)David Ritchie (13 shared papers)Monica A. Slavin (5 shared papers)Rachel Koldej (6 shared papers)Benjamin W. Teh (1 shared paper)Gabrielle M. Haeusler (1 shared paper)Andrew Grigg (5 shared papers)Jean Hendy (2 shared papers)
Journals: Blood (6 papers)British Journal of Haematology (3 papers)Bone Marrow Transplantation (3 papers)European Journal Of Haematology (2 papers)Pathology (2 papers)
Partner nations: Australia United States New Zealand

In The Last Decade

Lynette Chee

25 papers receiving 316 citations

Peers

Countries citing papers authored by Lynette Chee

Since Specialization

Citations

This map shows the geographic impact of Lynette Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette Chee more than expected).

Fields of papers citing papers by Lynette Chee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette Chee. The network helps show where Lynette Chee may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynette Chee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynette Chee Line = papers co-authored together Lynette Chee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CAR-T cell therapy and infection: a review Expert Review of Anti-infective Therapy ·Olivia Bupha‐Intr, Gabrielle M. Haeusler, Lynette Chee, Karin Thursky, Monica A. Slavin, Benjamin W. Teh	2020	66
2	Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy British Journal of Haematology ·Narendranath Epperla, Ang Li, Brent R. Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf, Lynette Chee, Edward A. Copelan, César O. Freytes, Peiman Hematti, Hillard M. Lazarus, Mark R. Litzow, Taiga Nishihori, Richard F. Olsson, Tim Prestidge, Wael Saber, Baldeep Wirk, Jean A. Yared, Alison W. Loren, Marcelo C. Pasquini	2020	56
3	Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021 Internal Medicine Journal ·Anna Khanina, Shio Yen Tio, Michelle Ananda‐Rajah, Sarah Kidd, Eloise Williams, Lynette Chee, Karen Urbancic, Karin Thursky	2021	30
4	Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation Blood Advances ·Ashvind Prabahran, Rachel Koldej, Lynette Chee, David Ritchie	2021	29
5	Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies Journal of Infection ·Lynette Chee, M. Brown, Joe Sasadeusz, Lachlan MacGregor, Andrew Grigg	2008	25
6	ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells Leukemia ·Lynette Chee, Jean Hendy, Louise E. Purton, Grant A. McArthur	2012	18
7	Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation Bone Marrow Transplantation ·Lynette Chee, Mark Tacey, Bernice Lim, Angelina Lim, Jeff Szer, David Ritchie	2017	16
8	Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation Leukemia & lymphoma ·Ashvind Prabahran, Rachel Koldej, Lynette Chee, Eric Wong, David Ritchie	2021	12
9	Myeloid somatic mutation panel testing in myeloproliferative neoplasms Pathology ·David M. Ross, Candice Thomson, Nada Hamad, Steven Lane, Kate Manos, Andrew Grigg, Belinda B. Guo, Wendy N. Erber, Ashleigh Scott, Nick Viiala, Lynette Chee, Maya Latimer, Courtney Tate, Carolyn Grove, Andrew C. Perkins, Piers Blombery	2021	11
10	The granulocyte-colony stimulating factor receptor (G-CSFR) interacts with retinoic acid receptors (RARs) in the regulation of myeloid differentiation Journal of Leukocyte Biology ·Lynette Chee, Jean Hendy, Louise E. Purton, Grant A. McArthur	2012	8
11	Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant Transplant Infectious Disease ·Julian Lindsay, Jad Othman, Michelle K. Yong, David Ritchie, Lynette Chee, KimHeng Tay, Shio Yen Tio, Ian Kerridge, Keith Fay, William Stevenson, Chris Arthur, Sharon C.‐A. Chen, David C. M. Kong, Matthew Greenwood, Steven A. Pergam, Catherine Liu, Monica A. Slavin	2021	7
12	Prognostic markers in core‐binding factor AML and improved survival with multiple consolidation cycles of intermediate‐/high‐dose cytarabine European Journal Of Haematology ·Ashvind Prabahran, Mark Tacey, Shaun Fleming, Andrew H. Wei, Courtney Tate, Paula Marlton, Joel Wight, Andrew Grigg, Annabel Tuckfield, Jeff Szer, David Ritchie, Lynette Chee	2018	7
13	Durable Clinical Benefit with Ker-050 Treatment: Findings from an Ongoing Phase 2 Study in Participants with Lower-Risk MDS Blood ·María Díez‐Campelo, David M. Ross, Aristoteles Giagounidis, Shuhying Tan, Thomas Cluzeau, Lynette Chee, David Valcárcel, Montserrat Arnán, Christine Graham, Allie McGinty, Miranda Ross, Wei Feng, Ying Jiang, Suresh Bobba, Montagu Hankin, Christopher Rovaldi, Dena Grayson, Simon Cooper, Jen L. Salstrom	2023	6
14	The Economic and Health Utilization Cost of Clinically Significant Cytomegalovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation Blood ·Michelle K. Yong, Shio Yen Tio, Jake Valentine, Joe Sasadeusz, Lynette Chee, Ashish Bajel, David Ritchie, Monica A. Slavin	2019	5
15	Clinical Outcomes of Chronic Myeloid Leukaemia (CML) Patients on Asciminib through the Managed Access Program (MAP) in Australia Blood ·Lynette Chee, Nora Lee, Andrew Grigg, Melissa Chen, Anthony P. Schwarer, Jeff Szer, David T Yeung, Timothy P. Hughes, Naranie Shanmuganathan	2022	4
16	Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review Bone Marrow Transplantation ·Ashvind Prabahran, Rachel Koldej, Lynette Chee, Jeff Szer, David Ritchie	2022	3
17	Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement Pathology ·Anoop Enjeti, Rishu Agarwal, Piers Blombery, Lynette Chee, Chong Chyn Chua, Andrew Grigg, Nada Hamad, Harry Iland, Steven Lane, Andrew C. Perkins, Deepak Singhal, Courtney Tate, Ing Soo Tiong, David M. Ross	2022	3
18	The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR Bone Marrow Transplantation ·David Kliman, Steven Tran, Glen Kennedy, Cameron Curley, Angela R. McLean, David Gottlieb, John Kwan, David Ritchie, Lynette Chee, Andrew Spencer, Duncan Purtill, Peter Bardy, Stephen Larsen, Nicole Chien, Travis Perera, Matthew Greenwood, Nada Hamad, John J. Moore	2022	3
19	Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia Internal Medicine Journal ·Lynette Chee, Nora Lee, Andrew Grigg, Melissa Chen, Anthony P. Schwarer, Jeff Szer, Sumita Ratnasingam, Sonia Raj, Pohan Lukito, David T Yeung, Timothy P. Hughes, Naranie Shanmuganathan	2024	2
20	Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype Cell Death and Disease ·Stephen Qi Rong Wong, Mohua Das, Kenzom Tenzin, Niranjan Shirgaonkar, Huiwen Chua, Lynette Chee, Ann S. J. Yeoh, Astley Aruna Murugiah, Wei Yong Chua, Madelaine Skolastika Theardy, Ethan Jadon Subel, Matan Thangavelu Thangavelu, Jane Vin Chan, Choon Kong Yap, Iain Bee Huat Tan, Petros Tsantoulis, Sabine Tejpar, Jia Min Loo, Ramanuj DasGupta	2025	2

About Lynette Chee

Lynette Chee is a scholar working on Hematology, Genetics, Transplantation, Applied Microbiology and Biotechnology and Immunology, having authored 29 papers that have together received 320 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Cytomegalovirus and herpesvirus research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Transplantation: Methods and Outcomes (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Transplantation (39 citations), Hematology (129 citations), Genetics (53 citations), Applied Microbiology and Biotechnology (8 citations) and Oncology (97 citations). Lynette Chee has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Karin Thursky, David Ritchie, Monica A. Slavin, Rachel Koldej, Benjamin W. Teh, Gabrielle M. Haeusler, Andrew Grigg, Jean Hendy, Grant A. McArthur and Louise E. Purton. Their work appears in journals such as Blood, British Journal of Haematology, Bone Marrow Transplantation, European Journal Of Haematology and Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact